The Journal of Clinical Endocrinology & Metabolism · 2008 · 176 citations · 17 references
MedicineCardiologyEndocrinologyRenal PathologyRenal PathophysiologyRenal Replacement TherapyGlomerular FiltrationRenal DiseaseRenal Function TestsRenal ImpairmentCreatinine-based BiomarkersGlomerular Filtration AssessmentGlomerular Filtration Rate AssessmentGlomerular Filtration Rate MeasurementLow Body Mass IndexOrgan Damage AssessmentSerum Creatinine AssessmentSystolic Blood Pressure
CONTEXT: Primary aldosteronism (PA) is associated with vascular end organ damage. OBJECTIVE: We evaluated the newly established German Conn's Registry for evidence of renal impairment and compared the data with those from hypertensive subjects of a population-based survey. DESIGN: We conducted a case-control study. PATIENTS AND CONTROLS: A total of 408 patients with PA from the Conn's registry treated in five German centers were matched for age, sex, and body mass index in a 1:1 ratio with 408 hypertensive control subjects from the population-based F3 survey of the Kooperative Gesundheitsforschung in the region of Augsburg (KORA). MAIN OUTCOME MEASURES: We measured serum creatinine and calculated glomerular filtration rate (GFR). RESULTS: The percentage of patients with a serum creatinine concentration above the normal range of 1.25 mg/dl was higher in patients with PA than in hypertensive controls (29 vs. 10%; P < 0.001). Regression analysis showed that age, male sex, low potassium, and high aldosterone concentrations were independent predictors of a lower GFR. Adrenalectomy reduced systolic blood pressure from a mean of 160 to 144 mm Hg. In parallel, we observed an increase in serum creatinine and a decrease of GFR from 71 to 64 ml/min (P < 0.001). A similar trend was seen after spironolactone treatment. CONCLUSIONS: In a large cohort of patients with PA, markers of disease activity such as plasma aldosterone and serum potassium are independent predictors of a lower GFR. Specific interventions, such as adrenalectomy or spironolactone treatment, are associated with a further decline in GFR.
17
John W. Funder, Robert M. Carey, Carlos Fardella et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 1.6K citations · Full text
The modification of diet in renal disease study group
Gerald J. Beck, Richard L. Berg, Cecil H. Coggins et al. · Controlled Clinical Trials · 1991 · 814 citations